Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections
- 1 July 2001
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 175 (2) , 112-116
- https://doi.org/10.5694/j.1326-5377.2001.tb143544.x
Abstract
Advances in antiviral therapy have involved both development of new, effective drugs and modification of pre‐existing drugs or regimens to increase effectiveness. New agents against influenza virus ...Keywords
This publication has 18 references indexed in Scilit:
- Antiviral Therapy for Herpes Zoster: Randomized, Controlled Clinical Trial of Valacyclovir and Famciclovir Therapy in Immunocompetent Patients 50 Years and OlderArchives of Family Medicine, 2000
- Resistance of influenza viruses to neuraminidase inhibitors — a reviewAntiviral Research, 2000
- Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trialThe Pediatric Infectious Disease Journal, 2000
- Valganciclovir HydrochlorideDrugs of the Future, 2000
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJAMA, 1999
- Recent advances in antiviral therapy.Journal of Clinical Pathology, 1999
- The Low Potential for Drug Interactions with ZanamivirClinical Pharmacokinetics, 1999
- Coadministration of Orally Inhaled Zanamivir with Inactivated Trivalent Influenza Vaccine Does Not Adversely Affect the Production of Antihaemagglutinin Antibodies in the Serum of Healthy VolunteersClinical Pharmacokinetics, 1999
- Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive VolunteersClinical Pharmacokinetics, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997